Abstract
A promising approach to investigate molecular details of brain function is the study of the mechanism of action of centrally active drugs. This may shed light not only on the causes underlying those diseases which are ameliorated by the respective drugs, but also on the process of normal brain function. In the case of benzodiazepines, we may hope that the clarification of their mechanism of action could provide an insight into the basis of the disease states which are ameliorated by benzodiazepine treatment, such as anxiety, insomnia, muscle spasms and convulsions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.E. Study and J.L. Barker, Diazepam and (-) pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of GABA responses in cultured central neurons, Proc. Natl. Acad. Sci. USA 78: 7180 (1981).
H. Möhler and T. Okada, Demonstration of benzodiazepine receptors in the central nervous system, Science 198: 849 (1977).
R.F. Squires and C. Braestrup, Benzodiazepine receptors in rat brain, Nature 266: 732 (1977).
L.-R. Chang, E.A. Barnard, M.M.S. Lo and J.O. Dolly, Molecular sizes of benzodiazepine receptors and the interacting GABA receptors in the membrane are identical. FEBS Lett. 126: 309 (1981).
H. Möhler, M.K. Battersby and J.G. Richards, Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label, Proc, Natl. Acad. Sci. USA 77: 1666 (1980).
W. Sieghart and M. Karobath, Molecular heterogeneity of benzodiazepine receptors, Nature 286: 285 (1980).
M. Karobath and G. Sperk, Stimulation of benzodiazepine receptor binding by γ-aminobutyric acid, Proc. Natl. Acad. Sci. USA 76: 1004 (1979).
I.L. Martin and J.M. Candy, Facilitation of benzodiazepine binding by sodium chloride and GABA, Neuropharmacology 17: 993 (1978).
J.F. Tallman, J.W. Thomas and D.W. Gallager, GABAergic modulation of benzodiazepine binding site sensitivity, Nature 274: 384 (1978).
G.J. Wastek, R.C. Speth, I.D. Reisine and H.I. Yamamura, The effect of gamma-aminobutyric acid on 3H-flunitrazepam binding in rat brain, Eur. J. Pharmacol. 50: 445 (1978).
C. Braestrup, M. Nielsen and C.E. Olsen, Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors, Proc. Natl. Acad. Sci. USA 77: 2288 (1980).
C. Braestrup and M. Nielsen, GABA reduces binding of 3H-methyl-β-carboline-3-carboxylate to brain benzodiazepine receptors, Nature 294: 472 (1981).
C. Braestrup and M. Nielsen, 3H-methyl-β-carboline-3-carboxylate as a selective radioligand for the BZi benzodiazepine receptor subclass, J. Neurochem. 37: 333 (1981).
C. Braestrup, R. Schmiechen, G. Neff, M. Nielsen and E.N. Petersen, Interaction of convulsive ligands with benzodiazepine receptors, Science 216: 1241 (1982).
M. Nielsen and C. Braestrup, Ethyl-β-carboline-3-carboxylate shows differential benzodiazepine receptor interaction, Nature 286: 606 (1980).
M. Nielsen, H. Schou and C. Braestrup, 3H-Propyl-β-carboline-3-carboxylate binds specifically to brain benzodiazepine receptors, J. Neurochem. 36: 276 (1981).
P. Pole, E.P. Bonetti, R. Schaffner and W. Haefely, A three state model of the benzodiazepine receptor explains the interaction between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquillizers, β-carbolines, and pheno- barbitone, Naunyn-Schmiedeberg’s Arch. Pharmacol. 321: 260 (1982)
W. Hunkeler, H. Möhler, L. Pieri, P. Pole, E.P. Bonetti, R. Schaffner and W. Haefely, Selective antagonists of benzodiazepines, Nature 290: 514 (1981).
A. Darragh, M. Scully, R. Lambe, I. Brick, C. O’Boyle and W.W. Downie, Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788, Lancet 2: 8 (1981).
H. Möhler and J.G. Richards, Agonist and antagonist benzodiazepine interaction in vitro, Nature 294: 763 (1981).
M.K. Battersby, J.G. Richards and H. Mohler, Benzodiazepine receptor: Photoaffinity labeling and localization, Eur. J. Pharmacol. 57: 277 (1979).
P. Schoch and H. Mohler, Purified benzodiazepine receptorretains modulation by GABA, Eur. J. Pharmacol. 95: 323 (1983)
P. Bernard, K. Bergen, R. Sobiski and R.D. Robson, CGS 8216 (2-phenylpyrazolo[4,3-c]quinolin-3-[5H]-one), an orally effective benzodiazepine antagonist, Pharmacologist 23: 150 (1981).
H. Möhler, W.P. Burkard, H.H. Keller, J.G. Richards and W. Haefely, Benzodiazepine antagonist Ro 15-1788: Binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels, J. Neuro. chem. 33: 714 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Möhler, H. (1985). Benzodiazepine Receptor: Structural Aspects and Modes of Ligand Interactions. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Psychiatry the State of the Art. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2363-1_82
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2363-1_82
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9446-7
Online ISBN: 978-1-4613-2363-1
eBook Packages: Springer Book Archive